Document is current
Any future updates will be listed below
-
Authors
Vogel, Julia
Carpinteiro, Alexander
Luedike, Peter
Buehning, Florian
Wernhart, Simon
Rassaf, Tienush
Michel, Lars
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Accepted: 20 May 2024
First Online: 29 May 2024
Declarations
:
: A.C. reports personal fees outside of the submitted work from Amgen, Janssen, Pfizer. P.L. reports personal fees outside of the submitted work from Edwards. T.R. report personal fees and others from Edwards, Novartis, Bristol Myers Squibb, Bayer, Daiichi Sankyo und AstraZeneca and Pfizer. T.R. is a co-founder of Bimyo, a company focusing on the development of cardioprotective peptides. L.M. reports personal fees outside the submitted work from Bayer, Alnylam, AstraZeneca, IFFM e. V. and from Bund der Niedergelassenen Kardiologen (BNK). All other authors report no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
